Pioglitazone Hydrochloride

Product NDC
50090-1321
11-digit product format
500901321
Labeler code
50090
Product ID
50090-1321_f83f8b58-84aa-4985-9a7e-976248cc272e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
PIOGLITAZONE
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA200044
Marketing category
ANDA
Marketing start
2013-02-13
Marketing end
0000-00-00
Substance
PIOGLITAZONE HYDROCHLORIDE
Active strength
45 mg/1
Pharmacologic classes
Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-1321-0EA - Each50090-132142638855-0e8a-4774-8733-79e77969d50712018-11-06
50090-1321-1EA - Each50090-13213d607f74-677d-4c39-b908-25bec12c15a012018-11-06

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-1321-15009013210190 TABLET in 1 BOTTLE (50090-1321-1) 90 tablet2014-11-280000-00-00NoNoCurrent